News and Trends 30 Nov 2018
Update: UK Biotech Scores £5M Series A to Boost Next-Generation Cancer Antibodies
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M) with the participation of two…
Melanie De Almeida
About
Former journalist intern. Melanie has studied in Germany and Denmark and did an internship at Novo Nordisk, where she had a glimpse to the workings of pharma. She is now a Ph.D. student at the IMP in Vienna.Articles by Melanie De Almeida
In Depth 14 Nov 2018
Taking Biotech to the Next Level with Laboratory Automation
Automation is slowly taking over our lives, ranging from smart homes to self-driving cars. With experiments becoming ever more complex…
News and Trends 13 Mar 2018
French Biotech Takes its Oral Diabetes Drug to Phase III
Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug for type 2 diabetes, imeglimin.…
In Depth 6 Feb 2018
CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could it be used as a…
ADVERTISEMENT
News and Trends 5 Sep 2017
UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine
UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards Phase III. Originally Published 06/06/2017…
News and Trends 26 Jul 2017
Update: Potential Breakthrough Treatment for Deadly Lung Disease Starts Phase IIb
Update (26/07/2017): Verona Pharma has dosed the first patients in the PhaseIIb with RPL554 in patients with chronic obstructive pulmonary disease…
News and Trends 20 Jul 2017
Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links
Update (20/07/2017): The European Commision has granted LEO Pharma marketing authorization for Kyntheum (brodalumab), making it the first biologic drug that…
In Depth 11 Jul 2017
Regenerating the Body With Stem Cells – Hype or Hope?
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem…
Startup Scout 30 Jun 2017
This Danish Biotech Thinks it Can Tackle the Obesity Epidemic
Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and Zealand Pharma, Copenhagen is a…
News and Trends 29 Jun 2017
New Drug for Neuropathic Pain Is Forging its Way through the Clinic
Pharmaleads has scored positive results in a first Phase I trial for its DENKI peptide PL265 to treat chronic neuropathic pain. The…
ADVERTISEMENT
Interview 28 Jun 2017
Video: The Next Big Thing in Biotech according to Sofinnova’s Antoine Papiernik
Antoine Papiernik, Managing Partner at the famous European biotech VC Sofinnova, closed Refresh this year with a keynote on the…
More News! 27 Jun 2017
Green Biotech Enters Partnership to Advance the Infinite Recycling of Plastics
Carbios has teamed up with TechnipFMC in order to move Carbios' enzymatic recycling process for PET plastics from the laboratory…
Startup Scout 23 Jun 2017
This Newly Founded French Biotech is All About Vaccines
This week we visited the biotech hub Lyon, where one of our top biotechs Imaxio has recently founded Osivax to advance the…
News and Trends 22 Jun 2017
Novartis Scores Major Phase III Win with New Cardiovascular Drug
Novartis just announced that its anti-inflammatory drug, canakinumab, was able to clear a 10,000-plus patient Phase III trial for cardiovascular disease. Novartis…
Interview 21 Jun 2017
Video: Can Synbio Cure Malaria? – Fireside Chat with Oxitec’s CEO Hadyn Parry
In our fireside chat with Hadyn Parry, Clara had the chance to hear all about Oxitec's exciting technology that could…
News and Trends 21 Jun 2017
British Biotech Tops up its Cancer Pipeline with New TCR Therapy
Cell Medica just acquired Catapult Therapy TCR, set up by UK's CGT Catapult, gaining the rights to its TCR therapy…
ADVERTISEMENT
News and Trends 20 Jun 2017
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
Bayer's and Regeneron's blockbuster Eylea could be facing serious competition, as Novartis boasts with positive Phase III results for AMD.…
Interview 19 Jun 2017
Video: “Biotech is still in its Infancy” – Keynote by Boston’s Prominent Biotech VC
We were very excited that David Berry, General Partner at Flagship Pioneering, opened Refresh earlier this month with a keynote…
Startup Scout 16 Jun 2017
Meet the Swedish Biotech that is Set to Cure a Rare Kidney Disease
This week we visited the Scandinavian summer and had a look at the Swedish biotech Oxthera, which is developing cell-…
News and Trends 15 Jun 2017
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and Google's Verily to invest in…